Valved Graft PMCF Study

Description

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

Conditions

Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection

Study Overview

Study Details

Study overview

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

Valved Graft Post-Market Clinical Follow-up Study

Valved Graft PMCF Study

Condition
Aortic Valve Disease
Intervention / Treatment

-

Contacts and Locations

Birmingham

University Hospital - Univ. of Alabama at Birmingham (UAB), Birmingham, Alabama, United States, 35294

Ann Arbor

University of Michigan, Ann Arbor, Michigan, United States, 48104

Asheville

Mission Health & Hospitals, Asheville, North Carolina, United States, 28801

Philadelphia

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Pittsburgh

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States, 15213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement
  • * anticoagulation therapy intolerant
  • * active endocarditis
  • * anatomical or medical, surgical, psychological or social contraindications

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Abbott Medical Devices,

Study Record Dates

2029-09